An in-depth look to SYNACT PHARMA AB operating, investing, and financing activities

SYNACT free cash flow for Q3 24 is -24.08 M SEK. For 2023, SYNACT free cash flow was -100.18 M SEK and operating cash flow was -100.18 M SEK.